Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 40.

Finazzi, T; Rordorf, T; Ikenberg, K; Huber, G F; Guckenberger, M; Garcia Schueler, H I (2018). Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy. BMC Cancer, 18(1):395.

Vital, D; Holzmann, D; Huber, G F; Moch, H; Morand, G B; Ikenberg, K (2018). PD-L1 is a positive prognostic factor in squamous cell carcinoma of the nasal vestibule. Rhinology, 56(3):182-190.

Huber, G F; Hüllner, M; Schmid, C; Brunner, A; Sah, B; Vetter, D; Kaufmann, P A; von Schulthess, G K (2018). Benefit of 18F-fluorocholine PET imaging in parathyroid surgery. European Radiology, 28(6):2700-2707.

Pézier, T F; Widmer, G M; Huber, G F (2017). Pneumo-thorax/mediastinum/(retro)peritoneum/ - a full house of complications following JET ventilation. Acta Otorhinolaryngologica Italica, 37(1):72-75.

Meerwein, C M; Sekine, T; Veit-Haibach, P; Bredell, M G; Huber, G F; Huellner, M W (2017). Multi-slice SPECT/CT vs. lymphoscintigraphy and intraoperative gamma ray probe for sentinel node mapping in HNSCC. European Archives of Oto-Rhino-Laryngology, 274(3):1633-1642.

Klein, H J; Fuchs, N; Mehra, T; Schweizer, R; Giesen, T; Calcagni, M; Huber, G F; Giovanoli, P; Plock, J A (2016). Extending the limits of reconstructive microsurgery in elderly patients. Journal of Plastic, Reconstructive & Aesthetic Surgery, 69(8):1017-1023.

Maquieira, R; Haerle, S K; Huber, G F; Soltermann, A; Haile, S R; Stoeckli, S J; Broglie, Martina A (2016). No benefit for regional control and survival by planned neck dissection in primary irradiated oropharyngeal cancer irrespective of p16 expression. European Archives of Oto-Rhino-Laryngology, 273(7):1841-1848.

Stanimirov Rossi, O; Vital, Domenic; Soyka, M B; Roth, T N; Huber, G F; Holzmann, D (2015). Multilocular sinonasal malignant melanoma: a poor prognostic subgroup? European Archives of Oto-Rhino-Laryngology, 272(1):123-129.

Schilling, Clare; Stoeckli, Sandro J; Haerle, Stephan K; et al; Huber, G F (2015). Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. European Journal of Cancer, 51(18):2777-2784.

Ture, M; Barth, J; Angst, F; Aeschlimann, A; Schnyder, U; Zerkiebel, N; Perseus, J; Renner, C; Imesch, P; Fuchs, B; Huber, G F; Walt, H; Martin-Soelch, C; Jenewein, J (2015). Use of inpatient rehabilitation for cancer patients in Switzerland: Who undergoes cancer rehabilitation? Swiss Medical Weekly, 145:w14214.

Meerwein, C; Vital, D; Greutmann, M; Schmid, C; Huber, G F (2014). Totale Thyreoidektomie bei amiodaroninduzierter Hyperthyreose : Wann übersteigt das Risiko der konservativen Therapie das Risiko der chirurgischen Behandlung? HNO, 62(2):100-105.

Kastrinidis, N; Kuhn, F P; Hany, T F; Ahmad, N; Huber, G F; Haerle, Sn K (2013). 18F-FDG-PET/CT for the Assessment of the Contralateral Neck in Patients with Head and Neck Squamous Cell Carcinoma. The Laryngoscope, 123(5):1210-5.

Tordella, L; Koch, S; Salter, V; Pagotto, A; Doondeea, J B; Feller, S M; Ratnayaka, I; Zhong, S; Goldin, R D; Lozano, G; McKeon, F D; Tavassoli, M; Fritzsche, F; Huber, G F; Rössle, M; Moch, H; Lu, X (2013). ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63. Proceedings of the National Academy of Sciences of the United States of America, 110(44):17969-17974.

Veit-Haibach, P; Schmid, D; Strobel, K; Soyka, J D; Schaefer, N G; Haerle, S K; Huber, G F; Studer, G; Seifert, Burkhardt; Hany, T F (2013). Combined PET/CT-perfusion in patients with head and neck cancers. European Radiology, 23(1):163-173.

Rössle, M; Weber, C S; Züllig, L; Graf, N; Jochum, W; Stöckli, S J; Moch, H; Huber, G F (2013). EGFR expression and copy number changes in low T-stage oral squamous cell carcinomas. Histopathology, 63(2):271-278.

Züllig, L; Roessle, M; Weber, C; Graf, N; Haerle, S K; Jochum, W; Stoeckli, S J; Moch, H; Huber, G F (2013). High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. European Journal of Cancer, 49(8):1915-1922.

Broglie, M A; Soltermann, A; Rohrbach, D; Haile, S R; Pawlita, M; Studer, G; Huber, G F; Moch, H; Stoeckli, S J (2013). Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head and Neck, 35(12):1698-1706.

Morand, G; Vital, D; Pézier, T; Holzmann, D; Roessle, M; Cozzio, A; Huber, G F (2013). Merkel cell carcinoma of the head and neck: a single institutional experience. Journal of Skin Cancer, 2013:325086.

Broglie, M A; Haerle, S K; Huber, G F; Haile, S R; Stoeckli, S J (2013). Occult metastases detected by sentinel node biopsy in patients with early oral and oropharyngeal squamous cell carcinomas: Impact on survival. Head and Neck, 35(5):660-666.

Broglie, M A; Soltermann, A; Haile, S R; Röösli, C; Huber, G F; Schmid, S; Stoeckli, S J (2013). Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity. The Laryngoscope, 123(1):164-170.

Gurney, B A S; Schilling, C; Putcha, V; Alkureishi, L W; Alvarez, A J; Bakholdt, V; Barbier Herrero, L; Barzan, L; Bilde, A; Bloemena, E; Salces, C; Palma, P D; de Bree, R; Dequanter, D; Dolivet, G; Donner, D; Flach, G B; Fresno, M; Grandi, C; Haerle, S K; Huber, G F; Hunter, K; Lawson, G; Leroux, A; Lothaire, P H; Mamelle, G; Silini, E M; Mastronicola, R; Odell, E W; O'Doherty, M J; Poli, T; Rahimi, S; Ross, G L; Zuazua, J S; Santini, S; Sebbesen, L; Shoaib, T; Sloan, P; Sorensen, J A; Soutar, D S; Therkildsen, M H; Vigili, M G; Villarreal, P M; von Buchwald, C; Werner, J A; Wiegand, S; McGurk, M (2012). Implications of a positive sentinel node in oral squamous cell carcinoma. Head and Neck, 34(11):1580-1585.

Haerle, S K; Soyka, M B; Schmid, D T; Ahmad, N; Huber, G F; Crook, D W; Hany, T F (2012). Improved treatment outcomes with (18) F-FDG PET/CT for patients with advanced head and neck squamous cell carcinoma. Head and Neck, 34(9):1205-1211.

Huber, G F. Seltene Kopf-/ Halstumoren. 2012, University of Zurich, Faculty of Medicine.

Haerle, S K; Soyka, M B; Fischer, D R; Murer, K; Strobel, K; Huber, G F; Holzmann, D (2012). The value of (18)F-FDG-PET/CT imaging for sinonasal malignant melanoma. European Archives of Oto-Rhino-Laryngology, 269(1):127-133.

Vorburger, M S; Broglie, M A; Soltermann, Al; Haerle, S K; Haile, S R; Huber, G F; Stoeckli, S J (2012). Validity of frozen section in sentinel lymph node biopsy for the staging in oral and oropharyngeal squamous cell carcinoma. Journal of Surgical Oncology, 106(7):816-819.

Murer, K; Huber, G F; Haile, S R; Stoeckli, S J (2011). Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma. Head and Neck, 33(9):1260-1264.

Haerle, S K; Fischer, D R; Schmid, D T; Ahmad, N; Huber, G F; Buck, A (2011). (18)F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with (18)F-FDG PET/CT. Molecular Imaging and Biology, 13(5):1036-1042.

Huber, G F; Gengler, C; Walter, C; Roth, T; Huber, A; Holzmann, D (2011). Adenocarcinoma of the nasal cavity and paranasal sinuses: single-institution review of diagnosis, histology, and outcome. Journal of Otolaryngology - Head and Neck Surgery, 40(1):34-39.

Huber, G F; Zullig, L; Soltermann, A; Roessle, M; Graf, N; Haerle, S K; Studer, G; Jochum, W; Moch, H; Stoeckli, S J (2011). Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer, 11:217.

Huber, G F; Albinger-Hegyi, A; Soltermann, A; Roessle, M; Graf, N; Haerle, S K; Holzmann, D; Moch, H; Hegyi, I (2011). Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma. Cancer, 117(20):4659-4670.

Huber, G F; Fritzsche, F R; et al (2011). Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. International Journal of Cancer, 129(6):1404-1409.

Haerle, S K; Huber, G F; Hany, T F; Ahmad, N; Schmid, D T (2010). Is there a correlation between (18)F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? European Archives of Oto-Rhino-Laryngology, 267(10):1635-40.

Broglie, M A; Huber, G F; Stöckli, S J; Studer, G (2010). Intensitätsmodulierte Radiotherapie beim Oropharynxkarzinom. In: 97. Frühjahresversammlung der SGORL, Zürich, Zürich, 17 June 2010 - 18 June 2010, S114-S116.

Schrepfer, T; Haerle, S K; Strobel, K; Schaefer, N; Hälg, R A; Huber, G F (2010). Wertigkeit des 18F-FDG-PET/CT beim Staging von primären Kopf-Hals-Lymphomen. In: 97. Frühjahresversammlung der SGORL, Zürich, Zürich, 17 June 2010 - 18 June 2010, S119-S121.

Roth, T N; Gengler, C; Huber, G F; Holzmann, D (2010). Outcome of sinonasal melanoma: Clinical experience and review of the literature. Head and Neck, 32(10):1385-1392.

Schrepfer, T; Haerle, S K; Strobel, K; Schaefer, N; Hälg, R A; Huber, G F (2010). The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. The Laryngoscope, 120(5):937-44.

Fritzsche, F R; Bode, P K; Stinn, B; Huber, G F; Noske, A (2009). Sialolipom der Glandula parotis. Der Pathologe, 30(6):478-480.

Huber, G F; Dziegielewski, P; Wayne Matthews, T; Dort, J C (2008). Head and neck osteosarcoma in adults: the province of alberta experience over 26 years. Journal of Otolaryngology - Head and Neck Surgery, 37(5):738-743.

Huber, G F; Khalil, M; Falck, V; Matthews, T W; Dort, J C (2008). Merkel cell carcinoma with solitary parotid metastasis: diagnostic dilemma in the absence of a primary site. Journal of Otolaryngology - Head and Neck Surgery, 37(1):E19-E21.

Aguzzi, A; Huber, G F (1998). How to fight brain cell suicide, and feel good at it. Cell Death and Differentiation, 5(10):803-804.

This list was generated on Thu Nov 15 12:01:39 2018 CET.